Chris Stevens's most recent trade in Rocket Pharmaceuticals Inc was a trade of 93,037 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rocket Pharmaceuticals Inc | Christopher Stevens | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 93,037 | 93,037 | - | - | Stock Option (Right to Buy) | |
| Rocket Pharmaceuticals Inc | Christopher Stevens | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 61,963 | 469,129 (0%) | 0% | 0 | Common Stock | |
| Rocket Pharmaceuticals Inc | Christopher Stevens | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2025 | 554,071 | 554,071 | - | - | Stock Option (Right to Buy) | |
| Rocket Pharmaceuticals Inc | Christopher Stevens | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2025 | 407,166 | 407,166 (0%) | 0% | 0 | Common Stock |